Evidence map›Paper›PMID 35402074›Full record

ArticleMolecular therapy. Nucleic acids2022

Inhibition of the lncRNA

Ziyang Wang, Ying Chang, Yue Liu, Bing Liu, Junhui Zhen, Xiaobing Li, Jiangong Lin, Qun Yu, Zhimei Lv, Rong Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Nucleic acids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ziyang WangDepartment of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.
Ying ChangDepartment of Geriatrics, Chongqing General Hospital, Chongqing 401147, China.
Yue LiuDepartment of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.
Bing LiuDepartment of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.
Junhui ZhenDepartment of Pathology, School of Medicine, Shandong University, Jinan, Shandong 250012, China.
Xiaobing LiInstitute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250062, China.
Jiangong LinDepartment of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.
Qun YuDepartment of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.
Zhimei LvDepartment of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.
Rong WangDepartment of Nephrology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong 250021, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Podocyte damage is strongly associated with the progression of diabetic nephropathy. Mitotic catastrophe plays an essential role in accelerating podocyte loss and detachment from the glomerular basement membrane. In the current study, we observed that the long non-coding RNA (lncRNA)

Indexed as

acetylationdiabetic nephropathyMIATmiR-130b-3pmitotic catastropheMTp53podocyteSox4ubiquitination

Identifiers

PMID35402074
PMCPMC8956887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.